title: Establishment and characterization of an arsenic-sensitive monoblastic leukaemia cell line (SigM5).
abstract: Few human monoblastic cell lines have been characterized to date. We have established the SigM5 cell line from a patient with acute monoblastic leukaemia (FAB M5a). Original leukaemic cells had a karyotype of 47,XY,+8, whereas the cell line showed a stemline clone of 81,XX,Y,Y,1,4,6,7,+8,+8,9,10,10,11,13,16,19[cp], with a minor sideline also present. Cytochemical staining was strongly positive with alpha-naphthylbutyrate acetate esterase, particulate positive with Sudan black and weakly positive for myeloperoxidase. Cells were positive for CD13, CD15, CD18, CD23, CD33, CD38, CD45, CD68 and myeloperoxidase. CD14 expression was 3-15%. SigM5 constitutively secreted interleukin (IL)-2, IL-8, IL-10, tumour necrosis factor (TNF)-alpha, ferritin, lysozyme, N-elastase and neopterin upon stimulation with interferon (IFN)-gamma. Cells expressed the proinflammatory mediator macrophage migration inhibitory factor (MIF). All NADPH oxidase subunits were constitutively present, but nitroblue tetrazolium reduction was only detectable upon activation with IFN-gamma. SigM5 monoblasts were sensitive to arsenic trioxide (As2O3) previously not described to induce apoptosis in monoblastic cells. Differing considerably in morphology, immunophenotype and sensitivity to arsenics from the widely used cell lines U937, HL-60 and THP-1, SigM5 is a new monoblastic cell line useful for studying leukaemogenesis, monocyte differentiation and tumour cell susceptibility to arsenic compounds.
authors.affiliation: Department of Medicine, Division of Haematology, University Hospital, Zürich, Switzerland.
authors.forename: R
authors.initials: R
authors.lastname: Walter
authors.forename: G
authors.initials: G
authors.lastname: Schoedon
authors.forename: E
authors.initials: E
authors.lastname: Bächli
authors.forename: D R
authors.initials: DR
authors.lastname: Betts
authors.forename: J P
authors.initials: JP
authors.lastname: Hossle
authors.forename: T
authors.initials: T
authors.lastname: Calandra
authors.forename: H I
authors.initials: HI
authors.lastname: Joller-Jemelka
authors.forename: J
authors.initials: J
authors.lastname: Fehr
authors.forename: A
authors.initials: A
authors.lastname: Schaffner
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology*; D018929:Cell Culture Techniques / Q000379:methods*; D002454:Cell Differentiation; D002460:Cell Line / Q000276:immunology / Q000473:pathology; D002898:Chromosomes, Human, Pair 8; D006801:Humans; D007621:Karyotyping; D007948:Leukemia, Monocytic, Acute / Q000235:genetics / Q000473:pathology*; D007963:Leukocytes, Mononuclear / Q000473:pathology*; D008854:Microscopy, Electron; D010087:Oxides / Q000494:pharmacology*; D011123:Polyploidy
chemical_list: D000970:Antineoplastic Agents; D001152:Arsenicals; D010087:Oxides; D000077237:Arsenic Trioxide